← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Larotrectinib currently has availability issues reported in 1 European register: Greece.
Limited availability ATC L01EX12 · also listed as: Larotrectinib · data refreshed 11 September 2026
As of 11 September 2026, 1 of the 9 tracked registers list current availability issues for Larotrectinib, covering 1 affected product presentation. The longest-running open report was filed in Greece on 2026-06-01 and has now been open for about 3 months. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. In the WHO ATC classification, Larotrectinib is coded L01EX12 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇬🇷 Greece | Limited availability VITRAKVI CAPS 100mg/cap BTx1 φιάλη (HDPE)x 56 καψάκια | 2026-06-01 | 2026-08-31 | Αυξημένη ζήτηση μέσω έκτακτης εισαγωγής. Εναλλακτικά άλλα σκευάσματα τ | register ↗ |
Every individual register entry for Larotrectinib in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇬🇷 GR | VITRAKVI CAPS 100mg/cap BTx1 φιάλη (HDPE)x 56 καψάκια | Limited availability | 2026-06-01 | 2026-08-31 | Αυξημένη ζήτηση μέσω έκτακτης εισαγωγής. Εναλλακτικά άλλα σκ |
Yes. As of 11 September 2026, availability issues are reported in: Greece. Availability is national — a shortage in one country does not mean it is short everywhere.
Directly from the official medicines-agency register that lists Larotrectinib: EOF limited-availability list (Greece). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Larotrectinib — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/larotrectinib/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Larotrectinib availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/larotrectinib/">Larotrectinib shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>